REQUEST A DEMO
Total
USD $0.00
Search more companies

Gintarine Vaistine UAB (Lithuania)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Pharmacies and Drug Stores
Full name: Gintarine Vaistine UAB Profile Updated: November 01, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

Gintarine Vaistine UAB is based in Lithuania. The head office is in Kaunas. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was incorporated on January 21, 2002. 1,001 - 5,000 (2024) employees currently work for Gintarine Vaistine UAB. From the latest financial highlights, Gintarine Vaistine UAB reported a net sales revenue increase of 12.03% in 2023. The enterprise’s net profit margin decreased by 1.52% in 2023.

Headquarters
Karmelavos sen. Ramuciu k. Erdves g. 2
Kaunas; Kaunas County; Postal Code: LT-52114

Contact Details: Purchase the Gintarine Vaistine UAB report to view the information.

Website: http://www.gintarine.lt

Basic Information
Total Employees:
Purchase the Gintarine Vaistine UAB report to view the information.
Outstanding Shares:
Purchase the Gintarine Vaistine UAB report to view the information.
Registered Capital:
Purchase the Gintarine Vaistine UAB report to view the information.
Incorporation Date:
January 21, 2002
Key Executives
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after Gintarine Vaistine UAB report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
12.03%
Total operating revenue
12.03%
Net Profit (Loss) for the Period
-48.08%
Total equity
-22.33%
Net Profit Margin
-1.52%
Return on Equity (ROE)
-15.74%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?